Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Characteristics and survival outcomes associated with the lack of radiation in the treatment of glioblastoma.

Huang B, Dolecek TA, Chen Q, Garcia CR, Pittman T, Villano JL.

Med Oncol. 2018 Apr 17;35(5):74. doi: 10.1007/s12032-018-1134-3.

PMID:
29667068
2.

National cancer database analysis of outcomes in pediatric glioblastoma.

Liu M, Thakkar JP, Garcia CR, Dolecek TA, Wagner LM, Dressler EVM, Villano JL.

Cancer Med. 2018 Apr;7(4):1151-1159. doi: 10.1002/cam4.1404. Epub 2018 Mar 13.

3.

Performance characteristics of digital vs film screen mammography in community practice.

Dabbous F, Dolecek TA, Friedewald SM, Tossas-Milligan KY, Macarol T, Summerfelt WT, Rauscher GH.

Breast J. 2017 Nov 5. doi: 10.1111/tbj.12942. [Epub ahead of print]

PMID:
29105900
4.

Absence of an anticipated racial disparity in interval breast cancer within a large health care organization.

Rauscher GH, Dabbous F, Dolecek TA, Friedewald SM, Tossas-Milligan K, Macarol T, Summerfelt WT.

Ann Epidemiol. 2017 Oct;27(10):654-658. doi: 10.1016/j.annepidem.2017.09.002. Epub 2017 Sep 20.

PMID:
28964641
5.

Demographics, patterns of care, and survival in pediatric medulloblastoma.

Dressler EV, Dolecek TA, Liu M, Villano JL.

J Neurooncol. 2017 May;132(3):497-506. doi: 10.1007/s11060-017-2400-5. Epub 2017 Mar 13.

6.

Impact of a False-Positive Screening Mammogram on Subsequent Screening Behavior and Stage at Breast Cancer Diagnosis.

Dabbous FM, Dolecek TA, Berbaum ML, Friedewald SM, Summerfelt WT, Hoskins K, Rauscher GH.

Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):397-403. doi: 10.1158/1055-9965.EPI-16-0524. Epub 2017 Feb 9.

7.

Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment Act.

Dolecek TA, Dressler EV, Thakkar JP, Liu M, Al-Qaisi A, Villano JL.

Cancer. 2015 Jul 15;121(14):2400-10. doi: 10.1002/cncr.29379. Epub 2015 Apr 14.

8.

Epidemiologic and molecular prognostic review of glioblastoma.

Thakkar JP, Dolecek TA, Horbinski C, Ostrom QT, Lightner DD, Barnholtz-Sloan JS, Villano JL.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):1985-96. doi: 10.1158/1055-9965.EPI-14-0275. Epub 2014 Jul 22. Review.

10.

Descriptive epidemiology of ependymal tumours in the United States.

Villano JL, Parker CK, Dolecek TA.

Br J Cancer. 2013 Jun 11;108(11):2367-71. doi: 10.1038/bjc.2013.221. Epub 2013 May 9.

11.

Oral and pharyngeal cancer in women.

Zavras AI, Shanmugam P, Shetty D, Dolecek TA, Kaste LM.

Dent Clin North Am. 2013 Apr;57(2):339-55. doi: 10.1016/j.cden.2013.02.001. Review.

PMID:
23570809
12.

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

Dolecek TA, Propp JM, Stroup NE, Kruchko C.

Neuro Oncol. 2012 Nov;14 Suppl 5:v1-49. doi: 10.1093/neuonc/nos218. Review. No abstract available. Erratum in: Neuro Oncol. 2013 May;15(5):646-7.

13.

Descriptive epidemiology of malignant and nonmalignant primary spinal cord, spinal meninges, and cauda equina tumors, United States, 2004-2007.

Duong LM, McCarthy BJ, McLendon RE, Dolecek TA, Kruchko C, Douglas LL, Ajani UA.

Cancer. 2012 Sep 1;118(17):4220-7. doi: 10.1002/cncr.27390. Epub 2012 Jan 3.

14.

Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data.

Davis FG, Dolecek TA, McCarthy BJ, Villano JL.

Neuro Oncol. 2012 Sep;14(9):1171-7. doi: 10.1093/neuonc/nos152. Epub 2012 Aug 16.

15.

Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registries.

McCarthy BJ, Shibui S, Kayama T, Miyaoka E, Narita Y, Murakami M, Matsuda A, Matsuda T, Sobue T, Palis BE, Dolecek TA, Kruchko C, Engelhard HH, Villano JL.

Neuro Oncol. 2012 Sep;14(9):1194-200. doi: 10.1093/neuonc/nos155. Epub 2012 Aug 6.

16.

Improved survival time trends for glioblastoma using the SEER 17 population-based registries.

Koshy M, Villano JL, Dolecek TA, Howard A, Mahmood U, Chmura SJ, Weichselbaum RR, McCarthy BJ.

J Neurooncol. 2012 Mar;107(1):207-12. doi: 10.1007/s11060-011-0738-7. Epub 2011 Oct 9.

17.

Age, gender, and racial differences in incidence and survival in primary CNS lymphoma.

Villano JL, Koshy M, Shaikh H, Dolecek TA, McCarthy BJ.

Br J Cancer. 2011 Oct 25;105(9):1414-8. doi: 10.1038/bjc.2011.357. Epub 2011 Sep 13.

18.

Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach.

Kim S, Dolecek TA, Davis FG.

Soc Sci Med. 2010 Jul;71(2):274-281. doi: 10.1016/j.socscimed.2010.03.033. Epub 2010 Apr 22.

19.

Neighborhood changes in concentrated immigration and late stage breast cancer diagnosis.

Cho YI, Johnson TP, Barrett RE, Campbell RT, Dolecek TA, Warnecke RB.

J Immigr Minor Health. 2011 Feb;13(1):9-14. doi: 10.1007/s10903-010-9339-3.

PMID:
20232147
20.

Prediagnosis food patterns are associated with length of survival from epithelial ovarian cancer.

Dolecek TA, McCarthy BJ, Joslin CE, Peterson CE, Kim S, Freels SA, Davis FG.

J Am Diet Assoc. 2010 Mar;110(3):369-82. doi: 10.1016/j.jada.2009.11.014.

PMID:
20184987
21.

Descriptive epidemiology of selected olfactory tumors.

Villano JL, Bressler L, Propp JM, Valyi-Nagy T, Martin IK, Dolecek TA, McCarthy BJ.

J Neurooncol. 2010 Oct;100(1):73-80. doi: 10.1007/s11060-010-0140-x. Epub 2010 Feb 13.

22.

Economic, racial and ethnic disparities in breast cancer in the US: towards a more comprehensive model.

Campbell RT, Li X, Dolecek TA, Barrett RE, Weaver KE, Warnecke RB.

Health Place. 2009 Sep;15(3):855-64. doi: 10.1016/j.healthplace.2009.02.007. Epub 2009 Feb 26.

23.

Neighborhood change and distant metastasis at diagnosis of breast cancer.

Barrett RE, Cho YI, Weaver KE, Ryu K, Campbell RT, Dolecek TA, Warnecke RB.

Ann Epidemiol. 2008 Jan;18(1):43-7. Epub 2007 Sep 24.

PMID:
17890103
24.

A path model of smoking cessation in women smokers of low socio-economic status.

Manfredi C, Cho YI, Crittenden KS, Dolecek TA.

Health Educ Res. 2007 Oct;22(5):747-56. Epub 2006 Dec 20.

PMID:
17182971
25.

Smoking cessation processes in low-SES women: the impact of time-varying pregnancy status, health care messages, stress, and health concerns.

Crittenden KS, Manfredi C, Cho YI, Dolecek TA.

Addict Behav. 2007 Jul;32(7):1347-66. Epub 2006 Nov 9.

26.

Relation of food and nutrient intakes to body mass in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial.

Stamler J, Dolecek TA.

Am J Clin Nutr. 1997 Jan;65(1 Suppl):366S-373S. doi: 10.1093/ajcn/65.1.366S.

PMID:
8988948
27.

Nutritional adequacy of diets reported at baseline and during trial years 1-6 by the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial.

Dolecek TA, Johnson RL, Grandits GA, Farrand-Zukel M, Caggiula AW.

Am J Clin Nutr. 1997 Jan;65(1 Suppl):305S-313S. doi: 10.1093/ajcn/65.1.305S.

PMID:
8988944
28.

Adherence to dietary recommendations in the special intervention group in the Multiple Risk Factor Intervention Trial.

Van Horn L, Dolecek TA, Grandits GA, Skweres L.

Am J Clin Nutr. 1997 Jan;65(1 Suppl):289S-304S. doi: 10.1093/ajcn/65.1.289S.

PMID:
8988943
29.

Methods of dietary and nutritional assessment and intervention and other methods in the Multiple Risk Factor Intervention Trial.

Dolecek TA, Stamler J, Caggiula AW, Tillotson JL, Buzzard IM.

Am J Clin Nutr. 1997 Jan;65(1 Suppl):196S-210S. doi: 10.1093/ajcn/65.1.196S.

PMID:
8988938
30.

Brief description of the Multiple Risk Factor Intervention Trial.

Kjelsberg MO, Cutler JA, Dolecek TA.

Am J Clin Nutr. 1997 Jan;65(1 Suppl):191S-195S. doi: 10.1093/ajcn/65.1.191S.

PMID:
8988937
31.

Maximizing recruitment efforts in a drug lipid-lowering trial with dietary intervention to lower LDL cholesterol.

Dolecek TA, Bradham KH, Espeland MA, Margitic SE, Byington RP, Hoen H, Kappelle LJ.

Control Clin Trials. 1996 Feb;17(1):33-45.

PMID:
8721800
32.

Registered dietitian time requirements in the Modification of Diet in Renal Disease Study.

Dolecek TA, Olson MB, Caggiula AW, Dwyer JT, Milas NC, Gillis BP, Hartman JA, DiChiro JT.

J Am Diet Assoc. 1995 Nov;95(11):1307-12.

PMID:
7594128
33.

Community Clinical Oncology Program as a recruitment vehicle for cancer control research. The Southeast Cancer Control Consortium experience.

Paskett ED, Cooper MR, DeGraffinreid CR, Spurr CL, Dolecek TA.

N C Med J. 1995 Jun;56(6):283-6. No abstract available.

PMID:
7603584
35.

Differential reduction of plasma cholesterol by the American Heart Association Phase 3 Diet in moderately hypercholesterolemic, premenopausal women with different body mass indexes.

Cole TG, Bowen PE, Schmeisser D, Prewitt TE, Aye P, Langenberg P, Dolecek TA, Brace LD, Kamath S.

Am J Clin Nutr. 1992 Feb;55(2):385-94.

PMID:
1734676
36.

Current perspectives: cardiovascular nutrition education. Introduction.

Dolecek TA.

Patient Educ Couns. 1992 Feb;19(1):3-4. No abstract available.

PMID:
1298946
37.

Changes in body weight, body composition, and energy intake in women fed high- and low-fat diets.

Prewitt TE, Schmeisser D, Bowen PE, Aye P, Dolecek TA, Langenberg P, Cole T, Brace L.

Am J Clin Nutr. 1991 Aug;54(2):304-10.

PMID:
1858694
38.

Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT).

Dolecek TA, Granditis G.

World Rev Nutr Diet. 1991;66:205-16. No abstract available.

PMID:
2053338
39.

Cardiovascular risk factor knowledge and belief in prevention among adults in Chicago.

Dolecek TA, Schoenberger JA, Oman JK, Kremer BK, Sunseri AJ, Alberti JM.

Am J Prev Med. 1986 Sep-Oct;2(5):262-7.

PMID:
3453189
40.

Increasing the use of meatless meals: a nutrition intervention substudy in the Multiple Risk Factor Intervention Trial (MRFIT).

Daniel-Gentry J, Dolecek TA, Caggiula AW, Van Horn LV, Epley L, Randall BL.

J Am Diet Assoc. 1986 Jun;86(6):778-81.

PMID:
3519738
41.

A long-term nutrition intervention experience: lipid responses and dietary adherence patterns in the Multiple Risk Factor Intervention Trial.

Dolecek TA, Milas NC, Van Horn LV, Farrand ME, Gorder DD, Duchene AG, Dyer JR, Stone PA, Randall BL.

J Am Diet Assoc. 1986 Jun;86(6):752-8.

PMID:
3519737
42.

Dietary intake in the Multiple Risk Factor Intervention Trial (MRFIT): nutrient and food group changes over 6 years.

Gorder DD, Dolecek TA, Coleman GG, Tillotson JL, Brown HB, Lenz-Litzow K, Bartsch GE, Grandits G.

J Am Diet Assoc. 1986 Jun;86(6):744-51.

PMID:
3519736
43.

Ingredients in nutrition education: family involvement, reading and race.

Sunseri AJ, Alberti JM, Kent ND, Schoenberger JA, Dolecek TA.

J Sch Health. 1984 May;54(5):193-6.

PMID:
6564304

Supplemental Content

Loading ...
Support Center